Bowman Christal C, Selgrade Maryjane K
Immunotoxicology Branch, Experimental Toxicology Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA.
Toxicol Sci. 2008 Mar;102(1):100-9. doi: 10.1093/toxsci/kfm288. Epub 2007 Nov 21.
An animal model for food allergy is needed to assess genetically modified food crops for potential allergenicity. The ideal model must produce allergic antibody (IgE) to proteins differentially according to known allergenicity before being used to accurately identify potential allergens among novel proteins. The oral route is the most relevant for exposure to food antigens, and a protein's stability to digestion is a current risk assessment tool based on this natural route. However, normal laboratory animals do not mount allergic responses to proteins administered orally due to oral tolerance, an immunologic mechanism which specifically suppresses IgE. To circumvent oral tolerance and evoke differential IgE responses to a panel of allergenic and nonallergenic food extracts, female C3H/HeJ mice were exposed subcutaneously or orally with cholera toxin as an adjuvant. All foods elicited IgE by the subcutaneous route. Oral exposure, however, resulted in IgE to allergens (peanut, Brazil nut, and egg white) but not to nonallergens (spinach and turkey), provided that the dose and exposures were limited. Additionally, in vitro digestibility assays demonstrated the presence of digestion-stable proteins in the allergenic food extracts but not in the nonallergenic foods. Our results suggest that the subcutaneous route is inadequate to distinguish allergens from nonallergens, but oral exposure under the appropriate experimental conditions will result in differential allergic responses in accordance with known allergenicity. Moreover, those foods containing digestion-resistant proteins provoke allergic responses in this model, supporting the current use of pepsin resistance in the decision tree for potential allergenicity assessment.
需要一种食物过敏动物模型来评估转基因粮食作物的潜在致敏性。理想的模型必须根据已知的致敏性,对蛋白质产生差异过敏抗体(IgE),然后才能用于准确识别新蛋白质中的潜在过敏原。经口途径与食物抗原暴露最为相关,基于这种自然途径,蛋白质对消化的稳定性是当前的一种风险评估工具。然而,由于口服耐受这种特异性抑制IgE的免疫机制,正常实验动物对经口给予的蛋白质不会产生过敏反应。为了规避口服耐受并引发对一组致敏和非致敏食物提取物的差异IgE反应,雌性C3H/HeJ小鼠经皮下或经口暴露于霍乱毒素作为佐剂。所有食物经皮下途径均可引发IgE。然而,经口暴露在剂量和暴露有限的情况下,会导致对过敏原(花生、巴西坚果和蛋清)产生IgE,但对非过敏原(菠菜和火鸡)则不会。此外,体外消化率测定表明,致敏食物提取物中存在抗消化稳定的蛋白质,而非致敏食物中则不存在。我们的结果表明,皮下途径不足以区分过敏原和非过敏原,但在适当的实验条件下经口暴露会根据已知的致敏性产生差异过敏反应。此外,那些含有抗消化蛋白质的食物在该模型中会引发过敏反应,这支持了目前在潜在致敏性评估决策树中使用胃蛋白酶抗性。